Ibrilparant
Ibrilparant is a LPA1 receptor antagonist with an IC50 of 0.00753 μM. Ibrilparant exhibits LPA1 calcium flux antagonistic activity, with an IC50 of 3.02 nM. Ibrilparant can be used in research related to various diseases such as cancer and inflammatory diseases.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2978107-47-8
- 화학식: C25H31NO5
- 분자량:425.52
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
LPA1 Receptor |
Ibrilparant (compound 355) exerts potent functional antagonistic activity against LPA1 in CHO-K1 cells overexpressing human LPA1 and G15a, with an IC50 of 0.00753 μM[1].
Ibrilparant exhibits potent LPA1 calcium flux antagonistic activity in CHO-K1 cells overexpressing human LPA1 and G15a, with an IC50 of 3.02 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2978107-47-8
-
분자량 425.52
-
화학식 C25H31NO5
-
SMILES
O=C(C1(CCOCC1)NC2=CC=C(C(COC3CC3)=C2)C4=C(C)C(OCC)=CC=C4)O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)